Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

PYPD

PYPD News

Newswire

08:33

PolyPid Receives FDA Support for NDA Submission of D-PLEX100 for Surgical Site Infections

08:32

PolyPid's D-PLEX100 Receives FDA Approval for NDA Submission, Rolling Review Process

08:40

PolyPid to discuss D-PLEX100 at ROTH Capital Partners virtual KOL event.

11:46

PolyPid: Roth Capital Maintains Buy Rating with Lower PT of $9

07:40

PolyPid advances FDA meeting, NDA submission, and commercial manufacturing readiness.

View More

About PYPD

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More